Diagnostics & Testing

CloudLIMS is a configurable, cloud-based LIMS delivered as SaaS for biobanks, clinical, research, cannabis, environmental, and analytical testing labs. It supports sample and subject management, test and inventory workflows, client portals, QA/QC, instrument integration, and reporting to help laboratories automate operations, support compliance such as ISO 17025, and stay audit-ready without on-premise IT infrastructure.

Countable Labs is a private genomics technology company that develops the Countable PCR platform for true single-molecule DNA quantification. Using ~30 million compartments per reaction, Countable PCR delivers 0.004% MAF sensitivity, <1% CV precision, and 6-log dynamic range for oncology, rare event detection, NIPT, infectious disease, and cell and gene therapy workflows.

Cryologyx is a University of Warwick spin-out biotech developing next-generation cryoprotectants and cryopreserved, assay-ready cells for medicines discovery, diagnostics, and cell-based therapies. Its patented molecular shield technology aims to improve cell and blood cell quality after thawing, supporting more reliable drug discovery workflows and future applications in transfusion and advanced therapies.

BioEcho Life Sciences (DNA & RNA Extraction Solutions) provides EchoLUTION single‑step DNA/RNA purification kits and EchoCLEAN cleanup solutions for diagnostics, biopharma R&D, agriculture and academic research. Their phenol‑ and chloroform‑free, high‑throughput formats deliver inhibitor‑free nucleic acids for qPCR, NGS and other genomic applications, from cell culture and tissue to FFPE, viral and plant samples.

DeciBio is a private, boutique strategy consulting and market intelligence firm focused on precision medicine and life sciences. It provides diagnostics, pharma, biotech, and research tools companies with biomarker and diagnostics strategy, market research, pricing, go-to-market, and data analytics services to support R&D and commercialization decisions across the precision medicine ecosystem.

10x Genomics is a public biotechnology company that delivers single cell, spatial, and in situ omics platforms used widely in oncology, immunology, neuroscience, and drug development. Its Chromium, Atera, Xenium, and Visium platforms enable high‑resolution characterization of tissues, tumors, and immune responses, supporting target discovery, biomarker development, and AI‑driven R&D across pharma and translational research.

DiaCarta is a precision molecular diagnostics company specializing in oncology and infectious disease testing using proprietary XNA and isobDNA™ technologies. It offers liquid biopsy-based cancer assays, NGS panels, bladder and colorectal cancer tests, OTC at‑home screening, and FDA‑EUA mpox PCR tests, backed by an ISO 13485 GMP facility and a CAP-accredited CLIA lab in California with global reach.

Diasorin is a global diagnostics specialist in immunodiagnostics, molecular diagnostics and licensed technologies, offering LIAISON® immunoassay systems, Simplexa™ and LIAISON NES® molecular tests, and Luminex xMAP® multiplex platforms. Its portfolio spans infectious disease, respiratory, GI, TB and hepatitis testing plus custom assay development, serving clinical labs, hospital networks and life science researchers.

EKF Diagnostics is an AIM‑listed global diagnostics and biotechnology company headquartered near Cardiff, UK, with manufacturing in the USA and Germany. It offers point‑of‑care analyzers, central laboratory tests and media, and life sciences reagents and enzymes for healthcare, research and industrial applications across hematology, diabetes, connectivity, women’s health, sports, veterinary and bioprocessing.

ELGA LabWater, part of Veolia Water Technologies, provides laboratory water purification systems for research, analytical, clinical and healthcare labs. Its PURELAB and MEDICA ranges deliver purified and ultrapure water using integrated technologies like reverse osmosis, ion exchange, filtration and UV to support sensitive applications such as HPLC, PCR and diagnostics.

Endometrics is a diagnostics company developing a unique, non-invasive menstrual-blood-based test for earlier detection of endometriosis using proprietary molecular biomarkers. The company’s mission is to deliver accessible, affordable diagnostics that advance health equity in women’s health, enabling at-home testing and supporting both clinical practice and research on endometriosis.

Eppendorf is a global life science supplier that provides premium instruments, consumables, and services for liquid, cell, and sample handling workflows in research and industrial labs. Its portfolio spans pipettes, centrifuges, bioreactors, PCR devices, freezers, and plastics, supported by calibration and service tools like the Eppendorf Service Portal, making it a strategic partner for pharma and biotech procurement and R&D teams.

Eremid Genomic Services is a genomics-focused CRO providing customized research and CLIA/CAP-accredited clinical genomics services across AgBiotech, Food & Nutrition, and Human Health. The company offers advanced sequencing, bioinformatics, and consultative project design from concept through data interpretation, leveraging long-read platforms and a specialist team based in Kannapolis, North Carolina.

Euroimmun is a Lübeck-based global manufacturer of medical laboratory diagnostics, specializing in immunoassays, reagents and automation systems for clinical laboratories across autoimmunity, infectious diseases, allergy, endocrinology and neurology. With more than 3,500 employees in 17 countries and products now part of Revvity’s portfolio, Euroimmun provides comprehensive test systems, instruments like IDS i20 and UNIQO160, and expert training via the Euroimmun Academy.

Exagen is a public, U.S.-based diagnostics company focused on autoimmune disease testing, especially rheumatology and lupus. Its AVISE portfolio supports diagnosis, prognosis, monitoring, and therapeutic drug monitoring for physicians and biopharma partners.

Excelra is a biopharma data and analytics specialist providing curated scientific data, the GOSTAR® SAR database, and end-to-end analytics services across drug discovery, development, and market access. Its multidisciplinary teams and proprietary platforms help pharma and biotech organizations accelerate R&D, enhance evidence generation, and support commercial decision-making from molecule to market.

biomodal is a private life sciences technology company based in Cambridge, UK that develops duet multiomics solutions for integrated genetic and epigenetic sequencing from low‑input DNA. Its duet evoC and duet +modC assays and software enable 6‑base or 5‑base genome analysis for applications such as liquid biopsy, cancer research, neurodegeneration, ageing and precision diagnostics using existing NGS platforms.

Fera (Fera Science Ltd) is a UK-based applied science organisation providing research, testing and consultancy across food, agri-tech and the environment. From food packaging and residue analysis to ecotoxicology, plant health and environmental fate studies, Fera supports R&D and procurement teams with science-led services that improve safety, sustainability and regulatory compliance across the agri-food chain.

BD Biosciences provides integrated flow cytometry instruments, reagents and workflow tools for research and clinical laboratories. Their portfolio includes advanced analyzers and sorters, multicolor dye panels, CAR detection reagents and standardized solutions backed by extensive training, technical support and online procurement resources.

Fortis Life Sciences is a private life science tools and services platform supplying antibodies, diagnostic components, molecular biology reagents, nanoparticles, and viral vectors, backed by ISO 13485 and GMP-compliant North American facilities. It offers catalog reagents, VHH libraries, and integrated antibody, viral vector, and diagnostic services for biopharma, diagnostics, and research customers worldwide.

GeneDx is a Nasdaq-listed genetic diagnostics company specializing in rare and inherited disease testing through whole exome sequencing, whole genome sequencing, and targeted panels. Its GeneDx Infinity™ platform provides biopharma partners with access to one of the world's largest rare disease datasets for drug discovery and clinical development.

Genomenon is a genomics intelligence company that uses AI and expert curation to transform biomedical literature into real‑world genomic evidence for biopharma and clinical labs. Its Mastermind genomic search engine, Cancer Knowledgebase, data products, and tailored services support variant interpretation, precision therapeutics, and clinical diagnostics across rare disease and oncology.

OGT (Oxford Gene Technology) provides precision genomic solutions via CytoCell FISH probes, SureSeq NGS panels and CytoSure arrays for haematological malignancies, solid tumours, cytogenetics and rare diseases. The company also offers precision medicine partnering for clinical trial assay and companion diagnostic development, supported by IVDR transition of its probes and FDA‑authorised CDx for KMT2A‑rearranged acute leukaemia.

Genomic Testing Cooperative is an oncology-focused diagnostics lab offering comprehensive DNA and RNA NGS profiling for solid tumors, hematologic malignancies, and liquid biopsy, including its cfDNA/cfRNA Liquid Trace® platform. The company combines rapid turnaround (typically 5–7 days), AI-based interpretation, and a cooperative business model to help hospitals and laboratories access advanced cancer genomics while managing cost, infrastructure, and reimbursement challenges.